The Bavarian Society for Obstetrics and Gynecology (BGGF), promoting gynecological and obstetric science, organized a symposium from 12 to 14 September 2019 at the Munich Klinikum Rechts der Isar. 

Tahovital GmbH attended the symposium and featured “tigovit”, green tea complex capsules. tigovit is currently being used as a treatment for Uterine fibroids in a research trial at the Women’s Hospital Charité.

tigovit founder Tanja Hohenester also presented their latest product: tigosol. tigosol is a pastilles (soft-lozenge), premium vitamin D complex containing a concentrated triple drug combination of green tea, the sun vitamin D3 and Bacillus subtilis cultures.

“With this unique composition, tigosol specifically combats deficiencies and helps the body absorb vitamin D” says Hohenester,



“tigosol is innovative and unique in the supplement market with the combination, vitamin D, green tea and the power bacterium Bacillus subtilis. Each soft-lozenge contains approximately one billion spores.”

The new tigosol vitamin D complex was synergistically balanced and developed to be an addition to the tigovit green tea complex. They can be taken together alone. Both of these premium supplements are optimal for the modern women in everyday life.


tigovit Makes US Debut at World Largest Anti-Aging Conference A4M